BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 34824199)

  • 1. Network medicine for disease module identification and drug repurposing with the NeDRex platform.
    Sadegh S; Skelton J; Anastasi E; Bernett J; Blumenthal DB; Galindez G; Salgado-Albarrán M; Lazareva O; Flanagan K; Cockell S; Nogales C; Casas AI; Schmidt HHHW; Baumbach J; Wipat A; Kacprowski T
    Nat Commun; 2021 Nov; 12(1):6848. PubMed ID: 34824199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational drug repositioning through heterogeneous network clustering.
    Wu C; Gudivada RC; Aronow BJ; Jegga AG
    BMC Syst Biol; 2013; 7 Suppl 5(Suppl 5):S6. PubMed ID: 24564976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Repurpose Drugs by Computational Analysis of Disease-Gene-Drug Associations.
    Gopal J; Prakash Sinnarasan VS; Venkatesan A
    J Comput Biol; 2021 Oct; 28(10):975-984. PubMed ID: 34242526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug repurposing improves disease targeting 11-fold and can be augmented by network module targeting, applied to COVID-19.
    Rivero-García I; Castresana-Aguirre M; Guglielmo L; Guala D; Sonnhammer ELL
    Sci Rep; 2021 Oct; 11(1):20687. PubMed ID: 34667255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MNBDR: A Module Network Based Method for Drug Repositioning.
    Chen HG; Zhou XH
    Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33375395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repositioning drugs by targeting network modules: a Parkinson's disease case study.
    Yue Z; Arora I; Zhang EY; Laufer V; Bridges SL; Chen JY
    BMC Bioinformatics; 2017 Dec; 18(Suppl 14):532. PubMed ID: 29297292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic integration of biomedical knowledge prioritizes drugs for repurposing.
    Himmelstein DS; Lizee A; Hessler C; Brueggeman L; Chen SL; Hadley D; Green A; Khankhanian P; Baranzini SE
    Elife; 2017 Sep; 6():. PubMed ID: 28936969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A computational approach to drug repurposing using graph neural networks.
    Doshi S; Chepuri SP
    Comput Biol Med; 2022 Nov; 150():105992. PubMed ID: 36228466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational Drug Repositioning with Random Walk on a Heterogeneous Network.
    Luo H; Wang J; Li M; Luo J; Ni P; Zhao K; Wu FX; Pan Y
    IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(6):1890-1900. PubMed ID: 29994051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptomic-Guided Drug Repositioning Supported by a New Bioinformatics Search Tool: geneXpharma.
    Turanli B; Gulfidan G; Arga KY
    OMICS; 2017 Oct; 21(10):584-591. PubMed ID: 29049014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using Drug Expression Profiles and Machine Learning Approach for Drug Repurposing.
    Zhao K; So HC
    Methods Mol Biol; 2019; 1903():219-237. PubMed ID: 30547445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational Drug Repurposing Based on a Recommendation System and Drug-Drug Functional Pathway Similarity.
    Shao M; Jiang L; Meng Z; Xu J
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of complemented comprehensive networks for rapid screening of repurposable drugs applicable to new emerging disease outbreaks.
    Nam Y; Lucas A; Yun JS; Lee SM; Park JW; Chen Z; Lee B; Ning X; Shen L; Verma A; Kim D
    J Transl Med; 2023 Jun; 21(1):415. PubMed ID: 37365631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heter-LP: A Heterogeneous Label Propagation Method for Drug Repositioning.
    Lotfi Shahreza M; Ghadiri N; Green JR
    Methods Mol Biol; 2019; 1903():291-316. PubMed ID: 30547450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considerations and challenges for sex-aware drug repurposing.
    Fisher JL; Jones EF; Flanary VL; Williams AS; Ramsey EJ; Lasseigne BN
    Biol Sex Differ; 2022 Mar; 13(1):13. PubMed ID: 35337371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computationally repurposing drugs for breast cancer subtypes using a network-based approach.
    Firoozbakht F; Rezaeian I; Rueda L; Ngom A
    BMC Bioinformatics; 2022 Apr; 23(1):143. PubMed ID: 35443626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Application of Computational Drug Repurposing Based on Transcriptomic Signatures.
    Karatzas E; Kolios G; Spyrou GM
    Methods Mol Biol; 2019; 1903():149-177. PubMed ID: 30547441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network-based drug ranking and repositioning with respect to DrugBank therapeutic categories.
    Re M; Valentini G
    IEEE/ACM Trans Comput Biol Bioinform; 2013; 10(6):1359-71. PubMed ID: 24407295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Literature-Based Knowledge Graph Embedding Method for Identifying Drug Repurposing Opportunities in Rare Diseases.
    Sosa DN; Derry A; Guo M; Wei E; Brinton C; Altman RB
    Pac Symp Biocomput; 2020; 25():463-474. PubMed ID: 31797619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptomic Data Mining and Repurposing for Computational Drug Discovery.
    Wang Y; Yella J; Jegga AG
    Methods Mol Biol; 2019; 1903():73-95. PubMed ID: 30547437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.